We are pleased to announce that the International conference on nursing will be held on Nov 04 - 06, 2020, Vienna, Wien, Austria. This Conference has been approved for a maximum of 10 CME Credits. Who Should Attend: Directors, CEO’s of Organizations Association, association presidents and professionals Ph.D. Scholars Noble laureates in Health Care and Medicine Professors, Associate Professors and Assistant Professors Graduates and Post Graduates Research Institutes and member. Course description: Nursing is the glue that holds a patient’s health care journey together. Nursing includes the promotion of health, prevention of illness, and the care of ill, disabled and dying people. Nursing is one of the most versatile and rewarding careers in healthcare today. The purpose of this conference is to provide the knowledge and tools whereby an individual may become an artist in the field of nursing. Why to attend? To let your research go global, and gain critical insights into modern science. Paves way to reach the right target audience. Deal with research requirements, scientific and operational challenges in the field. Highlights: • Meet Academia and Industry visionaries to get inspired • Expand your knowledge and find solutions to problems • Knowledge, Benchmarking and Networking offered at one place • Forge connections for global networking • Highly Organized and Structured Scientific programs • World class exhibitions and Poster presentations • Meet with vendors and suppliers Major Sessions: • Forensic Nursing • Types of Nursing • Nursing Education • Pediatric Nursing • Oncology Nursing • Surgical Nursing • Emergency Nursing • Neonatal Nursing • Critical - care Nursing • Cardiac Nursing

AOTrauma Masters Course - Challenges in Pediatric Trauma is organized by AOTrauma and will be held from Nov 05 - 06, 2020 at Imperial Riding School Renaissance Vienna Hotel, Vienna, Wien, Austria. Target Audience: Orthopaedic surgery, Paediatric surgery, Trauma surgery Description: In this course, participants will learn about current concepts in pediatric fracture and will gain valuable knowledge through a combination of lectures from experts, didactic case-based presentations and small group discussions where they are encouraged to discuss the cases and content in an open manner and to share their own experiences. During the practical exercises, participants gain insight by implementing the newly learned tips and tricks in surgical techniques on artificial bones as well as on artificial 3-D bone deformities. Other elements of this highly interactive learning environment will be the use of pre-operative planning as well as the latest fixation techniques to address the treatment of malunions and nonunions. Basic skills in instrumentation as well as the knowledge of techniques are required to benefit from this AOTrauma Master Course, therefore the AO Basic Principles Course of Fracture Management is a prerequisite to participate in this educational event. Learner Objectives: • Decision making in pediatric fractures of the upper and lower extremities, taking the question of age as well as co-factors like weight and growth disturbances into consideration • Fracture management of the pelvis and acetabulum • Fracture management with children and the growing bone at all ages, including complications Additional details will be posted as soon as information is available.

It is with great pleasure that we invite you to attend the “European Conference on Clinical Studies with Medical Devices and IVDs (CSMD2020)” which will take place 16-17 November 2020 in Vienna, Austria. Target Audience: • Medical Professionals • Quality assurance individuals working in the medical device and IVD ecosystem • Clinical Trials Specialists • R&D Personnel • CEOs • Regulatory Affairs Specialists • CROs / CRAs • Clinical Research Facility Managers & Entities • Pharmaceutical, Biomedical and Medical Device Industries • Start-Up Companies Course Description: The Conference is designed to address the most challenging and perplexing aspects of planning and conducting medical device and IVD clinical studies in accordance with the requirements of the European Medical Device Regulation (MDR, 2017/745) and the In Vitro Diagnostic Regulation (IVDR, 2017/746). Highly experienced and accomplished experts will share their knowledge and practical advice regarding the design, conduct and regulation of medical device and IVD clinical studies, including best practices and mistakes to avoid. Every effort will be made to provide practical, usable information to help attendees understand what must be done, but also avoid errors that will increase costs and extend timescales. The Conference will be of interest to all who are involved in planning, designing, conducting, sponsoring, evaluating or assisting in medical device or IVD clinical study-related activities. Topics to be covered during the conference: • Regulatory authority view of the new clinical study regulations • Notified Body procedures related to the evaluation of clinical investigations • Newly developed European guidance documents important for European clinical study conduct • International standards for conducting medical device and IVD studies: revised ISO 14155 and ISO 20916:2019 • Quality system concepts in clinical study planning, management, and regulatory compliance • Clinical Investigation Plans that meet regulatory and operational requirements • Key statistical elements of a successful clinical study • Critical considerations in site selection and subject enrollment • PMCF investigations, regulatory requirements and practical considerations • New medical device clinical safety reporting requirements • Investigator-initiated studies, new requirements, new considerations • Effective compliance with clinical study-related European privacy requirements • Manufacturer best practices for working with CRO’s We very much look forward to seeing you in Vienna. Maria E. Donawa, M.D. Conference Chair 

6th Annual Pre-Filled Syringes & Injectables Summit is organized by Vonlanthen Group of Companies and will be held from Nov 26 - 27, 2020 at Vienna, Wien, Austria. Who Should Attend: Chief Executives, Directors, Vice Presidents, Department Heads, Leaders, Senior Managers, Principal Scientists, Chemists and Engineers specialising in: • Bioprocess Research & Development • Business Development • CMC • Combination Products • Container Development • Controls & Robotics • Device Development & Manufacturing • Device Engineering & Design • Drug Delivery & Devices • Drug Development • Drug Packaging • External Supply • Extractables & Leachables • Fill/Finish • Formulation Sciences • Human Factors • Injectables • Materials Development • Medical & Connected Devices • Parenterals • PFS • QA/QC • Regulatory Affairs • Research & Development • Risk Management • Stability • Standardisation Science • Smart Devices • Sterile Products • Vaccines • Validation Description: During the 2-days networking experience, we will discuss the demand for efficient and convenient-to-use drug delivery devices that are used to improve patients’ experience and the key factors for the market growth advancing the technology. The demand for efficient and convenient-to-use drug delivery devices and improving a patient's experience are key factors for the market growth advancing the technology. This event has been designed for industry leaders to disclose new horizons and developments in pre-filled syringes (PFS) and injectable devices. Attending this event will provide a broad overview of current and upcoming EU MDR regulatory require­ments, innovative technologies, the impact of digitalisation, market trends and device needs. We will discuss the benefits of PFS and injection devices as the main factor for dosage ac­curacy, convenience and safe treatment for patients. They are excited to be hosting the 6th edition of our Pre-Filled Syringes & Injectables Summit and look forward to meeting you in Vienna in November! Key Practical Learning Points: • Overview of the upcoming EU MDR regulation and the role of notified bodies • Devices for self-injection: engineering challenges, trends and new developments • Strategic design: enhancing differentiation through a style guide • Integrating quality requirements • Analytical studies and chemical safety assessment • Manufacturing and processing technologies • The route to digital: the rise of digital therapeutics, and the new associated product landscape • Post-marketing safety reporting

European Society for Radiotherapy and Oncology (ESTRO) Congress 2020 is organized by European Society for Radiotherapy and Oncology (ESTRO) and will be held from Nov 28 - Dec 01, 2020 at Messe Wien Exhibition Congress Center, Vienna, Wien, Austria. This course has been approved for a maximum of 21 European CME credits (ECMEC®s). Blending a live program and digital participation Description: ESTRO is a multi-professional society focusing on radiation oncology as a core component of high- quality, multidisciplinary cancer treatment, in partnership with other oncology societies. Radiotherapy is a team effort, delivered by an interdisciplinary team consisting of radiation oncologists, clinical oncologists, medical physicists, radiobiologists, radiation therapists (RTTs) and nurses. The Society wishes to engage them all in their congress, together and in discussion with other oncology specialists. In line with the ESTRO vision 2030 ‘Radiation Oncology. Optimal Health for all, together’, ESTRO 2020 will convey the theme ‘Translating research and partnership into optimal health’. Advances in technologies and methodologies of radiation oncology continue to evolve very rapidly. However, these innovations will only truly provide an impact when the new findings can be translated into clinical applications that will result in optimal benefit for each individual patient in daily practice. Radiation oncology professionals should not try to achieve such optimal outcome by themselves but in dialogue and partnership with all relevant stakeholders: other oncology specialists at national, European and international level; patient representatives and advocates; and, industry partners. ESTRO 39 aims at stimulating all stakeholders to enhance and shape radiotherapy for optimal health for each cancer patient. The comprehensive scientific programme at ESTRO 39 offers state-of-the-art teaching lectures, symposia, debates on hot topics, as well as a range of educational activities such as pre-meeting courses, contouring workshops, and multidisciplinary tumor boards.  The interdisciplinary component of the scientific programme, getting more space compared to the past editions, will include sessions on the following topics: • How can AI improve contouring? • Spatially fractionated radiation therapy (SFRT) - GRID therapy • Cancer metabolism: implication for imaging, radiation response prediction, and tumor radiosensitization • Cardiac radio-ablation • FLASH: Radiotherapy with ultra-high dose rates • Ultra-hypofractionation for localized prostate cancer • Management of complex skin targets: which radiation technique • MR-guided Radiotherapy: state of the art and future perspectives • Preventing radiation-induced toxicity for the H&N region • Dose accumulation and re-irradiation for breast and thorax • How PROMS will change radiotherapy practice • Targeting microenvironment in radiotherapy: where are we now? • Redefining oligometastatic disease: incorporating advanced imaging into clinical trials • Combined radiotherapy and immunotherapy in NSCLC

European Conference on Embolotherapy (ET) 2020 is organized by Cardiovascular and Interventional Radiological Society of Europe (CIRSE) and will be held from Dec 16 - 19, 2020 at Vienna, Wien, Austria. Accreditation: The ET 2020 – European Conference on Embolotherapy, Vienna, Austria, 16/12/2020-19/12/2020 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 18 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. Description: In recent years, embolotherapy has become one of the core components of interventional radiology. While its established therapies remain essential for both IR and the medical community at large, embolotherapy is also an incredibly versatile field, constantly pushing the boundaries of innovation and embracing new clinical applications. With the support of an industry continuously pushing for improvements in tools and materials, cutting-edge embolisation treatments can be offered to an ever-growing number of patients. CIRSE strives to support this development through the European Conference on Embolotherapy (ET), providing interventional radiologists with the ideal platform to advance embolotherapy to become even more precise, evidence-based and impactful. With its five targeted session types, the ET 2020 programme aims to provide wide-ranging education on the field’s most of-the-moment topics, as well as established therapies. Additional details will be posted as soon as information is available.

International Conference on Complications in Interventional Radiology (ICCIR) 2020 is organized by Cardiovascular and Interventional Radiological Society of Europe (CIRSE) and will be held from Dec 16 - 18, 2020 at Messe Wien Exhibition Congress Center, Vienna, Wien, Austria. Complications are a delicate matter, but practitioners committed to continuously improving treatment results know that these must be confronted. The International Conference on Complications in Interventional Radiology (ICCIR) is a unique event that brings together professionals aware of this reality. While the ICCIR attracts interventional radiologists with diverse backgrounds, participants are united in their dedication to refining the subspecialty by scrutinising cases that did not go as planned. The congress exposes participants to a wide range of possible complications and gives them the opportunity to join distinguished faculty presenters in exploring how these can be avoided or best managed. To encourage frank exchanges, we strive to provide a particularly discreet and professional environment by carefully selecting faculty and limiting overall participation. Meticulously selected case reports also constitute a defining element of this congress. Participants have regularly lauded the congress for facilitating direct, open exchanges with colleagues presenting information based on their own real-life experience, with younger doctors especially appreciative of the opportunity to engage in thorough discussions outside of the busy workplace environment. Additional details will be posted as soon as information is available.

12th International course on ophthalmic and oculoplastic reconstruction and trauma surgery is organized by Brands Minds Media Communication GmbH (BMMC) and will be held from Jan 13 - 15, 2021 at Vienna General Hospital, Vienna, Wien, Austria. Accreditation: Participants from Austria will receive 30 DFP points. All participants will receive a certificate at the end of the course.  Goal: Proficiency in the theoretical foundations, the performance of different surgical techniques and the management of complications within complex oculoplastic and reconstructive operations of cornea, sclera, lids and lacrimal system.  Content and programme: The 3 day course consists of compact lectures which cover the theoretical basics for the following extensive hands-on wet-labs. The main topics are: • Suturing techniques (corneal, scleral, lid, lacrimal) • Lid reconstruction (skin grafts) • Lacrimal reconstruction (silicon ring intubation, bicanaliculary intubation to the nose) • Corneal laceration and perforations • Scleral rupture • Corneal transplantation • Keratoplasty à chaud • Globe rupture Additional details will be posted as soon as information is available.

European Society of Radiology (ESR) 2021 Conference is organized by European Society of Radiology (ESR) and will be held from Mar 03 - 07, 2021 at Vienna, Wien, Austria. Additional details will be posted as soon as information is available.

17th St.Gallen International Breast Cancer Conference 2021 is organized by St. Gallen Oncology Conferences (SONK) and will be held from Mar 17 - 20, 2021 at Austria Center, Vienna, Wien, Austria. Description: The conference co-chairs and the organisers invite you to the 17th outstanding St.Gallen International Breast Cancer Conference in Vienna, Austria, from 17 to 20 March 2021! Experts of virtually all major cooperative groups and centres world-wide actively engaged in basic and clinical Research as well as in clinical management of patients with breast cancer will present their latest data, critically reviewed by leading specialists in the field. Additional details will be posted as soon as information is available.